From: Gene therapy by electroporation for the treatment of chronic renal failure in companion animals
Assessment | Red Blood Cells | Hematocrit | Hemoglobin | Mean Red Cell Hemoglobin | ||
---|---|---|---|---|---|---|
Control | Day 0 | Average score n | 7.19 ± .4 n = 12 | 31.68 ± 1.5 n = 13 | 11.02 ± .5 n = 12 | 15.44 ± .4 n = 12 |
 | Day 20 | Average score % change P-value vs. Day 0 | 7.72 ± .5 7.3% P < 0.16 n = 7 | 32.87 ± 2.0 3.8% P < 0.30 n = 10 | 10.75 ± .8 -2.0% P < 0.35 n = 8 | 14.27 ± .6 -8.0% P < 0.06 n = 7 |
 | Day 40 | Average score % change P-value vs. Day 0 | 7.36 ± .6 2.3% P < 0.41 n = 8 | 32.17 ± 2.0 1.6% P < 0.38 n = 10 | 10.27 ± .9 -7.0% P < 0.05 n = 9 | 13.81 ± .7 -11.0% P < 0.03 n = 8 |
 | Day 60–75 | Average score % change P-value vs. Day 0 | 7.40 ± .3 2.9% P < 0.47 n = 7 | 32.10 ± 1.1 1.3% P < 0.32 n = 7 | 10.99 ± .5 -0.0% P < 0.25 n = 7 | 14.9 ± .6 -4.0% P < 0.08 n = 7 |
Treated | Day 0 | Average score n | 6.16 ± 0.3 n = 30 | 27.59 ± 1.1 n = 30 | 9.65 ± 0.7 n = 30 | 14.73 ± 0.2 n = 30 |
 | Day 20 | Average score % change P-value vs. Day 0 | 6.71 ± 0.3 9.0% P < 0.001 n = 29 | 30.46 ± 1.1 10.4% P < 0.0009 n = 29 | 10.11 ± 0.4 4.7% P < 0.22 n = 29 | 15.22 ± 0.3 3.3% P < 0.003 n = 29 |
 | Day 40 | Average score % change P-value vs. Day 0 | 6.35 ± 0.3 3.2% P < 0.06 n = 26 | 28.23 ± 1.1 2.3% P < 0.16 n = 26 | 9.65 ± 0.3 -0.07% P < 0.47 n = 26 | 15.32 ± 0.3 4.0% P < 0.001 n = 26 |
 | Day 60–75 | Average score % change P-value vs. Day 0 | 6.42 ± 0.4 4.3% P < 0.02 n = 19 | 29.18 ± 1.3 5.7% P < 0.03 n = 20 | 9.82 ± 0.5 1.6% P < 0.002 n = 19 | 15.46 ± 0.4 4.9% P < 0.004 n = 19 |